Hepatocellular Carcinoma Matrix NEO 2023Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy More info
Hepatocellular Carcinoma sCelLiVE 2023Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumor immunity and improves anti-PD-1 efficacy More info